No abstract available
Publication types
-
Comment
-
Comparative Study
-
Review
MeSH terms
-
Aged
-
Blood Pressure / drug effects
-
Cardiovascular Diseases / chemically induced
-
Celecoxib
-
Cyclooxygenase 2
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors / adverse effects*
-
Cyclooxygenase Inhibitors / economics
-
Cyclooxygenase Inhibitors / therapeutic use
-
Drug Costs
-
Female
-
Humans
-
Isoenzymes / antagonists & inhibitors
-
Lactones / adverse effects*
-
Lactones / economics
-
Lactones / therapeutic use
-
Male
-
Membrane Proteins
-
Prostaglandin-Endoperoxide Synthases
-
Pyrazoles
-
Risk Factors
-
Sulfonamides / adverse effects*
-
Sulfonamides / economics
-
Sulfonamides / therapeutic use
-
Sulfones
-
United States
Substances
-
Cyclooxygenase 2 Inhibitors
-
Cyclooxygenase Inhibitors
-
Isoenzymes
-
Lactones
-
Membrane Proteins
-
Pyrazoles
-
Sulfonamides
-
Sulfones
-
rofecoxib
-
Cyclooxygenase 2
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases
-
Celecoxib